1. Home
  2. PII vs VERA Comparison

PII vs VERA Comparison

Compare PII & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$50.34

Market Cap

3.4B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$39.96

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PII
VERA
Founded
1954
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
PII
VERA
Price
$50.34
$39.96
Analyst Decision
Hold
Strong Buy
Analyst Count
13
10
Target Price
$57.08
$81.30
AVG Volume (30 Days)
796.6K
968.6K
Earning Date
04-27-2026
05-27-2026
Dividend Yield
5.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,152,000,000.00
N/A
Revenue This Year
$1.52
N/A
Revenue Next Year
$4.29
$445.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.92
$18.53
52 Week High
$75.25
$56.05

Technical Indicators

Market Signals
Indicator
PII
VERA
Relative Strength Index (RSI) 24.18 42.61
Support Level $46.03 $19.84
Resistance Level $60.88 $56.05
Average True Range (ATR) 2.56 2.29
MACD -0.79 0.16
Stochastic Oscillator 5.17 39.02

Price Performance

Historical Comparison
PII
VERA

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: